Skip to main content
Clinical Trials/DRKS00004220
DRKS00004220
Completed
未知

The clinical success of the permanent posterior filling alternative Equia ®

GC Europe N.V.0 sites510 target enrollmentSeptember 6, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
K02
Sponsor
GC Europe N.V.
Enrollment
510
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 6, 2012
End Date
July 31, 2015
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
GC Europe N.V.

Eligibility Criteria

Inclusion Criteria

  • Dentate patients, no partial or full dentures, proximately three opposing zones with
  • occlusal contacts of natural teeth in the posterior region

Exclusion Criteria

  • Patients with CMD dysfunction or malfunction (signs of occlusal abrasion,
  • hyperfunction, clenching) will be excluded from the study. CMD\-Screening form according to DGZMK record.
  • Participants, who may not be willing to sign the consent form, will be withdrawn to
  • take part in the clinical investigation (according to Declaration of Helsinki and ICH E6
  • (R1\) GCP Guidelines, July 2002\).

Outcomes

Primary Outcomes

Not specified

Similar Trials